BeStock  
Markets › Compare › PLPC vs AMPH

PLPC vs AMPH

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PLPC · Preformed Line Products$246.78 ▼ 8.86%
AMPH · Amphastar Pharmaceuticals$28.25 ▲ 0.50%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

52104155206258Nov 24, '25May 26, '26Nov 20, '26
  • PLPC +26.8%
  • AMPH +5.8%

Head to head

MetricPLPCAMPH
Price$246.78$28.25
Change today▼ 8.86%▲ 0.50%
Market cap$1.20B$1.20B
Return, 3 months-39.3%+31.3%
Return, year to date+19.7%+5.5%
Return, 1 year+30.5%+8.6%
P/E (TTM)20.713.0
P/B2.31.5
P/E percentile vs own 5y78th35th
Dividend yield0.34%–
Revenue growth (YoY, latest qtr)+17.6%+8.2%
Net profit growth (YoY)+587.9%+117.7%
Gross margin32.4%46.8%
Operating margin10.1%18.7%
Net margin7.6%13.3%
Return on equity12.0%12.4%
Analyst target vs. price+94.5%-18.6%
Analyst buy share100%0%
RSI (14)3154
30-day volatility85.8%33.9%
Max drawdown, 1 year-48.6%-42.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuySell

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AMPH is the largest of the group by market value.
  • PLPC has returned the most over the past year.
  • AMPH carries the lowest trailing P/E.
  • PLPC is growing revenue fastest.
  • AMPH keeps the most profit per dollar of sales.
  • AMPH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top